DNA X Inc
SONM
23 hedge funds and large institutions have $17.3M invested in DNA X Inc in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 11 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 0.02% → 0.02% (-0.01%)
13% less capital invested
Capital invested by funds: $19.9M → $17.3M (-$2.62M)
18% less funds holding
Funds holding: 28 → 23 (-5)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$1.15M |
| 2 |
Renaissance Technologies
New York
|
+$1.01M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$850K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$319K |
| 5 |
Bank of New York Mellon
New York
|
+$141K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$1.86M |
| 2 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$1.35M |
| 3 |
USPCM
Union Square Park Capital Management
New York
|
-$698K |
| 4 |
NC
Nokomis Capital
Dallas,
Texas
|
-$464K |
| 5 |
Two Sigma Advisers
New York
|
-$229K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RA
26
Raffles Associates
New York
| – | -$218K | -167 | Closed |
|
27
Two Sigma Investments
New York
| – | -$100K | -77 | Closed |
|
|
AFM
28
Anson Funds Management
Dallas,
Texas
| – | -$97K | -74 | Closed |
|
|
TSS
29
Two Sigma Securities
New York
| – | -$40K | -30 | Closed |
|
30
Millennium Management
New York
| – | -$30K | -23 | Closed |
|
|
TRCT
31
Tower Research Capital (TRC)
New York
| – | -$7.05K | -4 | Closed |
|
32
JP Morgan Chase
New York
| – | -$3.53K | -2 | Closed |
|
33
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$1K | -1 | Closed |
|
34
Morgan Stanley
New York
| – | -$1.76K | -1 | Closed |
|
SONM Hedge Fund Activity: Q1 2021 in Review
23 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q1 2021, worth a combined $17.3M — down 13% from $19.9M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of SONM and 7 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was Perkins Capital Management, adding an estimated $1.15M. The largest seller was Phoenix Financial, exiting entirely with an estimated $1.86M sold.
- 23 institutional investors held DNA X Inc (SONM) as of Q1 2021, down from 28 in Q4 2020.
- Funds reported $17.3M of DNA X Inc stock for Q1 2021, down 13% quarter-over-quarter.
- 7 funds opened new DNA X Inc positions in Q1 2021 and 11 closed out, a net change of -4 holders.
- The largest DNA X Inc buyer in Q1 2021 was Perkins Capital Management, an estimated $1.15M added.
- The largest DNA X Inc seller in Q1 2021 was Phoenix Financial, an estimated $1.86M sold.
Based on aggregated 13F filings for Q1 2021.